Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Lorlatinib Exposed: A Far From Optimal Dose.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Lorlatinib Exposed: A Far From Optimal Dose.
Lorlatinib Exposed: A Far From Optimal Dose. Clin Pharmacol Ther. 2022 06; 111(6):1195-1196.
View in:
PubMed
subject areas
Aminopyridines
Carcinoma, Non-Small-Cell Lung
Humans
Lactams
Lactams, Macrocyclic
Lung Neoplasms
Protein Kinase Inhibitors
Pyrazoles
authors with profiles
Mark J. Ratain